Video Series
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11, and explore the practical implications of biosimilars in the broader real-world context.
Advertisement
Advertisement
Trending on Modern Retina
1
AAO highlight: Looking ahead to 2026
2
Evaluating Retinal Drying, Durability and IOP Management with Second-Generation Anti-VEGF Therapies in Retinal Vascular Diseases
3
Loading Dose Adjustments and Treatment Switching Strategies in Retinal Vascular Diseases
4
How AI is reshaping ophthalmology in 2025 and beyond
5